Companies / Johnson & Johnson
Johnson & Johnson
Financials · FY2025
Ownership
2.41B shares outstanding · as of Jul 17, 2026
Ownership
| Insiders | 0.03% | 844,266 |
| 10%+ / strategic | 10.10% | 243,455,135 |
| Institutions | 63.93% | 1,540,716,679 |
| Public float | 25.93% | 624,882,517 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 16
View all →| Insider | % of shares | Shares |
|---|---|---|
Duato JoaquinCEOCEO and Chairman of the Board · Director | 0.01% | 355,299 |
Taubert Jennifer LEVP, WWC. Innovative Medicine | <0.01% | 194,451 |
Wengel Kathryn EEVP, Chief TO and Risk Officer | <0.01% | 114,288 |
Swanson James D.EVP, CIO | <0.01% | 25,698 |
Schmid TimothyEVP, WW Chair, MedTech | <0.01% | 25,447 |
Reed John CEVP, Innovative Medicine, R&D | <0.01% | 24,911 |
Decker Robert JVP Corporate Controller | <0.01% | 23,682 |
Forminard ElizabethEVP, Chief Legal Officer | <0.01% | 23,568 |
Broadhurst VanessaEVP, Global Corp Affairs | <0.01% | 23,003 |
Mulholland KristenEVP, Chief HR Officer | <0.01% | 19,830 |
Institutional holders 4,501
View all →| Holder | Value | % of shares |
|---|---|---|
| $53.87B | 8.80% | |
| $49.74B | 9.97% | |
| $33.98B | 5.55% | |
| $14.42B | 2.46% | |
| $12.12B | 2.43% | |
| $9.59B | 1.92% | |
| $6.92B | 1.39% | |
| $6.54B | 1.31% | |
| $6.06B | 1.22% | |
| $5.86B | 1.18% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | Duato Joaquin CEO | Sell | Common Stock | $11.32M | -51K -39.14% | 79,634 <0.01% of shares | high |
| Jan 26, 2026 | Duato Joaquin CEO | Sell | Common Stock | $10.80M | -49K -61.26% | 30,852 <0.01% of shares | high |
| Feb 17, 2026 | Wolk Joseph J Executive | Sell | Common Stock | $8.10M | -33K -46.15% | 38,961 <0.01% of shares | medium |
| Feb 13, 2026 | Duato Joaquin CEO | Other | Common Stock | $7.75M | -32K -9.01% | 319,822 0.01% of shares | low |
| Feb 17, 2026 | Reed John C Executive | Sell | Common Stock | $7.27M | -30K -69.81% | 12,941 <0.01% of shares | medium |
| Feb 6, 2026 | Wengel Kathryn E Executive | Other | Common Stock | $6.54M | -27K -20.47% | 105,956 <0.01% of shares | low |
| Feb 17, 2026 | Wolk Joseph J Executive | Sell | Common Stock | $6.06M | -25K -64.07% | 14,000 <0.01% of shares | medium |
| Feb 13, 2026 | Swanson James D. Executive | Sell | Common Stock | $5.41M | -22K -47.00% | 25,020 <0.01% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Vanguard Group Inc | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| JNJ | — | 478160104 |